Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience
Table 1
Demographic and clinicopathological characteristics of the enrolled patients.
Character
CP dominant
FFP dominant
P value
Number
11
16
FFP/CP ratio
0.0015
Age(years)
0.53
Gender
1.00
male
5
8
female
6
8
PLASMIC score
0.39
5
1
0
6
8
11
7
2
5
Bentley score
0.43
20-30
8
8
>30
3
8
Platelet count (×109/L)
0.95
Uncorrected reticulocyte (%)
0.49
MCV (fL)
0.67
INR
0.04
Creatinine (μmol/L)
0.38
Indirect bilirubin (μmol/L)
0.58
Active cancer
1(9.09%)
1(6.25%)
1.00
D-dimer (ug/ml)
0.96
Procedures to complete response
0.04
Time to complete response (days)
0.04
Steroid use (%)
11(100%)
16(100%)
1.00
Vincristine use (%)
1(9.09%)
0(0%)
0.41
Cyclophosphamide use (%)
3(27.27%)
6(37.5%)
0.69
IVIg use (%)
4(36.36%)
10(62.5%)
0.25
Rituximab use (%)
1((9.09%)
2(12.5%)
1.00
IVIg: intravenous immunoglobulin; MCV: mean corpuscular volume; INR: international normalized ratio.
